Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia.

ABSTRACT:

SUBMITTER: Guolo F 

PROVIDER: S-EPMC5685236 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature